Volume 13; Issue 8

Main
The Lancet Oncology
Volume 13; Issue 8

The Lancet Oncology

Volume 13; Issue 8

1

Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis

Daniel Picard, Suzanne Miller, Cynthia E Hawkins, Eric Bouffet, Hazel A Rogers, Tiffany SY Chan, Seung-Ki Kim, Young-Shin Ra, Jason Fangusaro, Andrey Korshunov, Helen Toledano, Hideo Nakamura, James T

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 1.17 MB

english, 2012

2

Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

Freddie Bray, Ahmedin Jemal, Nathan Grey, Jacques Ferlay, David Forman

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 5.71 MB

english, 2012

3

Markers for individualised therapy in endometrial carcinoma

Helga B Salvesen, Ingfrid S Haldorsen, Jone Trovik

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 541 KB

english, 2012

4

Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

Paul H Sugarbaker, David P Ryan

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 390 KB

english, 2012

5

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

Qiujin Shen, Jia Fan, Xin-Rong Yang, Yexiong Tan, Weifeng Zhao, Yang Xu, Ning Wang, Yongdong Niu, Zheng Wu, Jian Zhou, Shuang-Jian Qiu, Ying-Hong Shi, Bin Yu, Ning Tang, Wei Chu, Min Wang, Jinhua Wu,

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 786 KB

english, 2012

6

Treatment decisions for elderly patients with haematological malignancies: a dilemma

Frédéric Peyrade, Lauris Gastaud, Daniel Ré, Sandrine Pacquelet-Cheli, Antoine Thyss

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 102 KB

english, 2012

7

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

Hai T Tran, Yuan Liu, Amado J Zurita, Ying Lin, Katherine L Baker-Neblett, Anne-Marie Martin, Robert A Figlin, Thomas E Hutson, Cora N Sternberg, Rafael G Amado, Lini N Pandite, John V Heymach

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 623 KB

english, 2012

8

Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis

Sashendra Senthi, Frank J Lagerwaard, Cornelis JA Haasbeek, Ben J Slotman, Suresh Senan

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 269 KB

english, 2012

9

Breast cancer in Mexico: a growing challenge to health and the health system

Yanin Chávarri-Guerra, Cynthia Villarreal-Garza, Pedro ER Liedke, Felicia Knaul, Alejandro Mohar, Dianne M Finkelstein, Paul E Goss

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 145 KB

english, 2012

10

CNS PNET molecular subgroups with distinct clinical features

André O von Bueren

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 46 KB

english, 2012

11

Cancer transition and priorities for cancer control

Milena Maule, Franco Merletti

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 42 KB

english, 2012

12

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

Gerald S Falchook, Karl D Lewis, Jeffrey R Infante, Michael S Gordon, Nicholas J Vogelzang, Douglas J DeMarini, Peng Sun, Christopher Moy, Stephen A Szabo, Lori T Roadcap, Vijay GR Peddareddigari, Pet

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 225 KB

english, 2012

13

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial

Jeffrey R Infante, Leslie A Fecher, Gerald S Falchook, Sujatha Nallapareddy, Michael S Gordon, Carlos Becerra, Douglas J DeMarini, Donna S Cox, Yanmei Xu, Shannon R Morris, Vijay GR Peddareddigari, Ng

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 246 KB

english, 2012

14

Biomarkers for early diagnosis of hepatocellular carcinoma

Alejandro Forner, Jordi Bruix

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 116 KB

english, 2012

15

The Cancer Drug Fund 1 year on—success or failure?

Peter Stephens, David Thomson

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 191 KB

english, 2012

16

Elderly people with glioblastoma

Alba Fiorentino, Mario Balducci, Silvia Chiesa, Vincenzo Fusco

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 48 KB

english, 2012

17

Elderly people with glioblastoma

Marc C Chamberlain

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 48 KB

english, 2012

18

Stereotactic ablative radiotherapy for inoperable stage I NSCLC

Nicolaus Andratschke

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 108 KB

english, 2012

19

Cancer care in South Africa

Raymond P Abratt, Lydia Dreosti, Paul Ruff

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 36 KB

english, 2012

20

Cancer detection in primary care

Greg Rubin, Georgios Lyratzopoulos, Gary Abel, Richard Neal, Fiona Walter, Willie Hamilton

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 48 KB

english, 2012

21

NICE guidance on abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen

Matthew Dyer, Fiona Rinaldi, Elisabeth George, Amanda I Adler

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 44 KB

english, 2012

22

Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2

Sally Doss, Janet Robertson, Jane Adam

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 42 KB

english, 2012

23

Biomarkers in personalised treatment of renal-cell carcinoma

Shahrokh F Shariat, Evanguelos Xylinas

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 95 KB

english, 2012

24

Cancer care in South Africa

W Szpak, MP Schickerling

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 47 KB

english, 2012

25

Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial

Andrea Necchi, Luigi Mariani, Nadia Zaffaroni, Lawrence H Schwartz, Patrizia Giannatempo, Flavio Crippa, Carlo Morosi, Rodolfo Lanocita, Teodoro Sava, Cinzia Ortega, Caterina Messina, Cosimo Sacco, Ma

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 223 KB

english, 2012

26

Adjuvant nodal irradiation in melanoma

Muhammad Khattak, Martin Gore, James Larkin, Dirk Strauss, Meirion Thomas, Andrew Hayes, Kevin Harrington

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 48 KB

english, 2012

27

NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer

Bernice Dillon, Bhash Naidoo, Helen Knight, Peter Clark

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 44 KB

english, 2012

28

European Medicines Agency assesses safety reporting at Roche

Hilary Marshall

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 56 KB

english, 2012

29

Potential therapeutic target for triple-negative breast cancer

Judith A Gilbert

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 96 KB

english, 2012

30

Data used to justify Indian HPV vaccination trial questioned

Soumyadeep Bhaumik

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 96 KB

english, 2012

31

US Supreme Court paves way for health reform

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 227 KB

english, 2012

32

The coming of age of MEK

Grant A McArthur

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 76 KB

english, 2012

33

Antiangiogenic treatment in metastatic urothelial cancer

Matthew D Galsky

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 46 KB

english, 2012

34

14th World Congress on Gastrointestinal Cancer

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 69 KB

english, 2012

35

Preimplantation genetic diagnosis for mutated BRCA genes

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 56 KB

english, 2012

36

Parent-controlled analgesia for paediatric pain management

Sherene Chen-See

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 65 KB

english, 2012

37

Natural gamma radiation and childhood leukaemia

Judith A Gilbert

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 65 KB

english, 2012

38

The state of chemotherapy in France

Martine Lochouarn

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 48 KB

english, 2012

39

Australia to be first country to vaccinate boys against HPV

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 51 KB

english, 2012

40

Adjuvant nodal irradiation in melanoma – Authors' reply

Bryan Burmeister, Michael Henderson, John Thompson

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 38 KB

english, 2012

41

Cancer care in South Africa

Lauren Pretorius

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 38 KB

english, 2012

42

Elderly people with glioblastoma – Authors' reply

Wolfgang Wick, Michael Weller

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 39 KB

english, 2012

43

Chemokine receptor blockade in graft-versus-host disease

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 51 KB

english, 2012

44

US Medicare to cut radiotherapy times and payments

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

45

One in five need reoperation after breast-conserving surgery

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

46

Healthy choice should be the easy choice

The Lancet Oncology

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

47

Will the medical student in the team please stand up?

Gabriel dos Anjos, Marc Peeters, Jeremy C Wyatt, Ricky A Sharma

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 86 KB

english, 2012

48

Death of a Superhero

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 135 KB

english, 2012

49

Angelight Films: lights, camera, cancer!

Olaya Astudillo

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 364 KB

english, 2012

50

Go With the Flow

Odhran O'Donoghue

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 412 KB

english, 2012

51

Dear video diary…

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 152 KB

english, 2012

52

Voices from the front: August

David M Mastrianni

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 152 KB

english, 2012